Scientists Find Human Antibodies that Can Block Multiple Coronaviruses Including SARS-CoV-2

Media Type
Article
Publish or Event Date
Research Institution
Scripps Research
Short Title
Scientists Find Human Antibodies that Can Block Multiple Coronaviruses Including SARS-CoV-2
Content Coordinator
Content Manager

Bird Flu Associated with Hundreds of Seal Deaths in New England in 2022, Tufts Researchers Find

Media Type
Article
Publish or Event Date
Research Institution
Tufts University Cummings School of Veterinary Medicine
Short Title
Bird Flu Associated with Hundreds of Seal Deaths in New England in 2022, Tufts Researchers Find
Content Coordinator
Content Manager

Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic

Media Type
Article
Publish or Event Date
Research Institution
University of California San Diego School of Medicine
Short Title
Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic
Content Coordinator
Content Manager

How A Viral Toxin May Exacerbate Severe COVID-19

December’s ACD Meeting—Featuring Bill Gates and Dr. Anthony Fauci

Funding News Editions:
See more articles in this edition

NIH’s Advisory Committee to the Director (ACD) held a hybrid meeting on December 8 and 9, 2022. As detailed in its Charter, ACD Members provide recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

For daily agendas and the full list of meeting materials, check the December 8-9, 2022 section of the ACD Meetings page. Find video recordings of the ACD presentations at:

NIAID’s extramural research community may be especially interested in the following topics:

The meeting also covered the following topics:

The next ACD meeting has not yet been scheduled but will likely occur in June 2023. Monitor the ACD Meetings page for updates.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.

Experimental Vaccines Offer Long-term Protection Against Severe COVID

Researchers from NAU, Washington Tackling an Elusive Valley Fever Vaccine

NIAID Signs Memorandum of Understanding with Sheba Medical Center of Israel

NIAID Now |

In December, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the Sheba Medical Center, part of Israel’s Ministry of Health, signed a Memorandum of Understanding to further infectious disease research collaborations between U.S.-funded and Israel-funded scientists. Signers of the agreement were Anthony S. Fauci, M.D., director of NIAID, and Yitshak Kreiss, M.D., director general of the Sheba Medical Center. 

The partnership grew out of a need for more cooperation in biomedical research, a critical part of preparing for the next pathogen of pandemic or endemic potential. The memorandum represents the continuation of the existing relationship between NIAID’s Vaccine Research Center (VRC) in Bethesda, Md., and Sheba Medical Center. 

Daniel Douek, M.D., Ph.D., chief of the VRC’s Human Immunology Section traveled to Israel to meet with representatives of Sheba and celebrate the opening of the Sheba Pandemic Preparedness Research Institute (SPRI). 

 “What this does is to formalize the relationship between our two organizations, not just legally so that we can exchange ideas and exchange materials and project intellectual property, but it formalizes the relationship at an intergovernmental level,” Douek said. “We’re already collaborating. We’ve been collaborating for a few years on COVID-19 and other projects.” 

A joint study published recently in Nature Communications found common immune responses in people infected with different SARS-CoV-2 variants, which may explain why COVID-19 vaccines against older variants continue to be effective against newer variants. 

Studies, consistent exchanges of research and scientific materials, and routine visits by scientists to both organizations will continue under the agreement. 

“Sheba needs the NIH, and the NIH needs Sheba for the future benefit of humanity,” Douek said.

Contact Information

Contact the NIAID Media Team.

301-402-1663
niaidnews@niaid.nih.gov

Search NIAID Blog

New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection

$4.3 Million NIAID Grant to Help with Pandemic Preparedness